Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07325227
PHASE4

Study of Remimazolam for Cataract Surgery

Sponsor: Fred E, Shapiro

View on ClinicalTrials.gov

Summary

The goal of this clinical trial is to learn if the use of the sedative remimazolam improves the safety of patients having cataract surgery by decreasing the number of sedation-related complications during and after surgery, and shortening post-surgical cognitive recovery time.

Official title: Remimazolam for Sedation in Cataract Surgery, A Phase IV, On-label, Blinded Study

Key Details

Gender

All

Age Range

55 Years - 90 Years

Study Type

INTERVENTIONAL

Enrollment

30

Start Date

2026-02-15

Completion Date

2027-12-01

Last Updated

2026-01-08

Healthy Volunteers

Yes

Interventions

DRUG

Arm 1 Cataract Surgery performed with remimazolam as sedative

Sedation will be remimazolam in one eye and the standard of care in the other eye.

DRUG

Arm 2 Cataract Surgery performed with standard of care sedative

Standard of care sedative will be used during surgery.

Locations (1)

Massachusetts Eye and Ear Infirmary

Boston, Massachusetts, United States